Helix Biogen Institute

Helix Biogen Institute is a Nigerian biotechnology company and translational biomedical research hub based in Ogbomoso, Oyo State. Founded in 2019 as Helix Biogen Consult, the institute specializes in genomics, molecular biology, bioinformatics, and vaccine design to address pressing infectious diseases and public health challenges in Africa. The company is notable for developing a COVID-19 vaccine candidate that was recognized on the World Health Organization's (WHO) Draft Landscape of COVID-19 Candidate Vaccines. Helix Biogen Institute leverages computational and immunoinformatics platforms to design mRNA-based and multi-epitope vaccines targeting pathogens such as Lassa virus, Mpox, and Mokola virus, alongside developing point-of-care diagnostic test kits for neglected tropical diseases.